Law360, New York (October 28, 2011, 3:39 PM ET) -- A Pennsylvania federal judge ruled Wednesday that a California county can't personally pursue a false advertising suit in multidistrict litigation over GlaxoSmithKline PLC's alleged concealment of the risks of diabetes medication Avandia, but that it can assert the claims on behalf of state residents.
In partially granting GSK's motion to dismiss the suit in, Judge Cynthia M. Rufe found that California's False Advertising Law does not allow the county of Santa Clara, Calif., to bring a suit — which alleges that GSK downplayed the cardiac risks...
County Can't Pursue Own Avandia False Ad Claims: Judge
To view the full article, take a free trial now.
